Loading...
Correction: Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer
Saved in:
| Published in: | J Immunother Cancer |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Publishing Group
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7883864/ https://ncbi.nlm.nih.gov/pubmed/33579740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001622corr1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|